Skip to content
About Everest
Menu Toggle
Brief Profile
Values
Quality Policy
Leadership
Plants
Locations
About Ruxotor Cream
Indications
Menu Toggle
Non- segmental vitiligo
Mild to Moderate Eczema
Patient Information Leaflet
Prescribing Information
Contact Us
Main Menu
About Everest
Menu Toggle
Brief Profile
Values
Quality Policy
Leadership
Plants
Locations
About Ruxotor Cream
Indications
Menu Toggle
Non- segmental vitiligo
Mild to Moderate Eczema
Patient Information Leaflet
Prescribing Information
Contact Us
Everest Pharma Launches RUXOTOR Cream, A Generic Version of FDA-Approved OPZELURA
FDA approves Ruxolitinib (Opzelura) for Vitiligo Therapy: A breakthrough in the field of dermatology
Ruxolitinib Cream Demonstrates Long-Term Safety and Effectiveness in Treating Atopic Dermatitis
Frequently Asked Question